ENDEFR
Home › Italy › V.F. PHARMA S.R.L.

V.F. PHARMA S.R.L.

Società A Responsabilità Limitata (SRL) · MILANO, Italy · LEI 815600E0D3135417C864
LEI active

Summary

V.F. PHARMA S.R.L. is registered in Italy and entered in the “Business Register (Registro delle Imprese)” under number 14448860966. Its legal form is Società A Responsabilità Limitata (SRL) – private limited company (Italy). According to GLEIF, its ultimate parent is FIRST CAPITAL SPA (Italy), which is also its direct parent. That group has 4 subsidiaries with LEIs in 1 country, 4 of them in Italy. The LEI was first issued on 5 Dec 2025 and the record was last updated on 5 Dec 2025; the next renewal is due by 5 Dec 2026.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formSocietà A Responsabilità Limitata (SRL)
private limited company (Italy)
RegisterBusiness Register (Registro delle Imprese) · Register website
Registration number14448860966
Registration authorityInfocamere
JurisdictionItaly
Registered addressVIALE LUIGI MAJNO, 17/A, 20122 MILANO, Italy
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)27 Nov 2025
LEI815600E0D3135417C864
LEI statusactive
LEI first issued5 Dec 2025
LEI record last updated5 Dec 2025
Next LEI renewal5 Dec 2026
Corroboration of the LEI recordfully corroborated

Group membership

FIRST CAPITAL SPA Italy ultimate parent
V.F. PHARMA S.R.L. this entity
View the whole group: 4 subsidiaries in 1 countries

Relationship to the parent

Direct parentUltimate parent
ParentFIRST CAPITAL SPAFIRST CAPITAL SPA
Accounting period5 Dec 2025 to 5 Dec 20265 Dec 2025 to 5 Dec 2026
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Accounting standardIFRSIFRS
Relationship start5 Dec 20255 Dec 2025
Recorded at GLEIF since5 Dec 20255 Dec 2025
Last updated5 Dec 20255 Dec 2025
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (3)